Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical data for SNSP-113 support its development as new approach to treat mucus stasis in CF

Nov. 5, 2019

KYM-003, potent and selective STAT3 degrader with strong antitumor activity in vivo

Nov. 5, 2019

Development of novel PRKACA inhibitors for the treatment of fibrolamellar carcinoma

Nov. 5, 2019

Positive interim safety and efficacy data presented for OTS Allocetra

Nov. 5, 2019

Harbour BioMed initiates first-in-human study of HBM-4003

Nov. 5, 2019

FDA approves Talicia for treatment of H. pylori in adults

Nov. 5, 2019

iRhom2 is fibrosis friend, not foe

Nov. 5, 2019

Gene therapy can treat, prevent heart failure

Nov. 5, 2019

Broad strategy for HIV bnAbs

Nov. 5, 2019

Dopamine goes from pleasure to repair molecule

Nov. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...